Organogenesis Holdings Inc.
ORGO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $535,441 | $464,284 | $545,597 | $421,354 |
| - Cash | $63,745 | $73,076 | $109,965 | $135,571 |
| + Debt | $40,810 | $40,816 | $42,633 | $43,312 |
| Enterprise Value | $512,506 | $432,024 | $478,265 | $329,095 |
| Revenue | $150,864 | $100,779 | $86,693 | $126,656 |
| % Growth | 49.7% | 16.2% | -31.6% | – |
| Gross Profit | $114,613 | $73,149 | $62,970 | $95,605 |
| % Margin | 76% | 72.6% | 72.6% | 75.5% |
| EBITDA | $27,260 | -$6,255 | -$15,893 | $14,641 |
| % Margin | 18.1% | -6.2% | -18.3% | 11.6% |
| Net Income | $21,567 | -$9,392 | -$18,843 | $7,673 |
| % Margin | 14.3% | -9.3% | -21.7% | 6.1% |
| EPS Diluted | 0.11 | -0.096 | -0.17 | 0.058 |
| % Growth | 214.3% | 43.4% | -392.6% | – |
| Operating Cash Flow | $3,079 | -$32,873 | -$19,935 | $10,937 |
| Capital Expenditures | -$2,235 | -$3,638 | -$3,626 | -$3,361 |
| Free Cash Flow | $844 | -$36,511 | -$23,561 | $7,576 |